GOSS: Gossamer Bio, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Gossamer Bio, Inc. (GOSS) o'ziga xos o'pka gipertoniyasi terapiyasi tizimini ishlab chiqmoqda va o'zini ajralmas ilmiy markaz sifatida namoyish etmoqda. GURU.Markets servisi P/E ko'rsatkichining kutilayotgan o'sish nisbati chiziqli grafigini taqdim etadi, bunda 0.00 ushbu metrika uchun yangi qiymatga aylanadi. Istiqbollar immunologik dori vositalari uchun uzoq muddatli patent himoyasi va ichki resurslarni optimallashtirishdan so'ng global sog'liqni saqlash gigantlari bilan strategik litsenziyalash ittifoqlariga asoslangan.
Gossamer Bio, Inc. (GOSS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Gossamer Bio, Inc.|GOSS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi gossamerbio.com|GOSS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Gossamer Corp|GOSS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Gossamer Bio|Shoshilinch likvidlik gossamerbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
GOSS - Kompaniyaning sof foydasi|Kompaniya foydasi prognozi Gossamer Bio, Inc.|GOSS - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Gossamer Bio Corp.|GOSS - PEG multiplikatori|EV/EBITDA multiplikatori Gossamer Corp|GOSS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Gossamer Bio|GOSS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi gossamerbio.com|GOSS - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Gossamer Bio, Inc.
Kompaniyaning umumiy tahlili:GOSS - Gossamer Bio Inc
Ushbu ko'rsatkich foyda ko'paytirish koeffitsiyentini foyda kengayish sur'ati bilan solishtiradi, kelajakdagi o'sish birligining tannarxini aniqlaydi va qiymat birdan pastga tushganda past baholangan aktivlarni belgilaydi. Gossamer Bio, Inc. (GOSS) uchun PEG koeffitsiyenti juda muhimdir, chunki u o'pka gipertenziyasiga qarshi dori vositasining potentsialini mavjud naqd pul zaxiralari va R&D risklariga nisbatan bozor baholashini aks ettiradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Pharvaris Pharma (PHVS)|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda tourmalinebio.com (TRML)|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Pharming Group NV (PHAR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Upstream Pharma|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|PEG multiplikatori immunome.com IMNM|KALV - Narxning foydaga va o‘sish sur’atiga nisbati|Septerna, Inc. (SEPN) - Narx-foyda va o‘sish multiplikatori|PVLA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Savara Pharma (SVRA)|Narxning foydaga va o‘sish sur’atiga nisbati Rigel Pharmaceuticals|ANAB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|Aclaris Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati kyvernatx.com KYTX|Tiziana Life Sciences Ltd (TLSA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Cabaletta Bio Inc. (CABA)|Narx-foyda va o‘sish multiplikatori VTYX|THTX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AVTX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati eledon.com|Narxning foydaga va o‘sish sur’atiga nisbati Agenus Inc. AGEN|CLYM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Zura Bio Limited - PEG multiplikatori|aTyr Pharmaceuticals (ATYR) - Narx-foyda va o‘sish multiplikatori|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|IMA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|STTK (Shattuck Labs Inc) - PEG multiplikatori|EQ - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|IMUX - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati InflaRx NV (IFRX)|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Adicet Bio ACET|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati INMB (INmune Bio Corporation)|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SABS|PEG multiplikatori Akari Therapeutics PLC (AKTX)|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|edesabiotech.com (EDSA) - Narx-foyda va o‘sish multiplikatori|IBIO: PEG multiplikatori|Carisma Therapeutics Inc. (CARM) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori XTLB|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HCWB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aptevotherapeutics.com|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|HIND (Vyome Holdings Inc) - Narx-foyda va o‘sish multiplikatori|revbiosciences.com (REVB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti SCNI (Scinai Immunotherapeutics Ltd)|PEG multiplikatori CALI|AFMD - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori ALLK (Allakos)|Narxning sof foyda o‘sishiga nisbati HOOKIPA Pharma, Inc.|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|TCBP - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
